Loading
Life sciences · Journal article
Acs Applied Materials & Interfaces · September 17, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Abstract Insufficient tumor accumulation and heat shock protein (HSP)-mediated adaptive resistance remain major barriers to effective cancer therapy. Here, a cysteine-inspired conjugated polymer photosensitizer (CP-PCys) was developed to integrate enhanced tumor accumulation, hydrogen sulfide (H2S) generation, photodynamic therapy (PDT), and photothermal therapy (PTT). Dense cysteine functionalization promoted cellular uptake, resulting in approximately 2.4-fold higher accumulation in 4T1 cells than that of the polyethylene glycol-functionalized control after 24 h. Meanwhile, the conjugated backbone enabled NIR-II fluorescence imaging, a photothermal conversion efficiency of 52.3%, and efficient reactive oxygen species generation (58.6%). Intracellular H2S disrupted energy metabolism and suppressed HSP70 expression, while PDT-generated reactive oxygen species further reinforced this effect. Combined irradiation reduced HSP70 expression to approximately 57% of the PBS control level, thereby sensitizing tumor cells to PTT. Conversely, PTT-induced hyperthermia enhanced reactive oxygen species generation and potentiated PDT, aggravating mitochondrial dysfunction and DNA damage. In 4T1 tumor-bearing mice, CP-PCys rapidly accumulated in tumors and produced stable mild photothermal heating. Combined PDT–PTT achieved an 89% tumor inhibition rate without detectable skin injury or systemic toxicity, demonstrating the potential of CP-PCys for effective and atraumatic cancer phototherapy.